You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

induction failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML Trial in Guanzhou (CLAG)

Not yet recruiting
  • AML
  • CLAG
  • Guanzhou, Guangdong, China
  • +1 more
May 16, 2023

Hemodynamic Instability, Anesthesia; Adverse Effect, Heart Failure Trial in Luleå (Preoperative colloid fluid bolus

Completed
  • Hemodynamic Instability
  • +4 more
  • Preoperative colloid fluid bolus (Gelofusine)
  • Preoperative transthoracic echocardiography
  • Luleå, Sweden
    Sunderby teaching hospital
Dec 15, 2021

Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Renal Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022

Hypotension in Heart Failure Patients Undergoing

Not yet recruiting
  • Blood Pressure, Low
  • (no location specified)
Oct 17, 2021

Renal Failure Trial in Chicago (Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion)

No longer available
  • Renal Failure
  • Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion
  • Chicago, Illinois
    Northwestern Memorial Hospital
Jul 15, 2022

Kidney Failure Trial in Chicago, Durham (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Kidney Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Nov 29, 2022

End-stage Renal Failure, Graft Rejection Trial in London (Tacrolimus (Kidney transplant maintenance immunosuppression), Kidney

Completed
Has Results
  • End-stage Renal Failure
  • Graft Rejection
  • Tacrolimus (Kidney transplant maintenance immunosuppression)
  • Kidney transplant maintenance immunosuppression
  • London, United Kingdom
    West London Renal & Transplant Centre, Hammersmith Hospital
Aug 26, 2021

Respiratory Failure, Hypotension and Shock, Hypotension on Induction Trial in Dayton (Norepinephrine, Lactated Ringers,

Recruiting
  • Respiratory Failure
  • +4 more
  • Dayton, Ohio
    Miami Valley Hospital Premier Health
Aug 9, 2022

Poor Response to Ovulation Induction, Infertility, Female, Ovarian Insufficiency Trial in Athens (Autologous platelet rich

Recruiting
  • Poor Response to Ovulation Induction
  • +5 more
  • Autologous platelet rich plasma
  • Athens, Attica, Greece
    Genesis Athens Clinic
Mar 15, 2022

Severe Hemophilia A Trial in Duarte (VWF/FVIII concentrates)

Completed
  • Severe Hemophilia A
  • VWF/FVIII concentrates
  • Duarte, California
    City of Hope Medical Center
Aug 18, 2021

Respiratory Failure Trial in Bern (Rapid sequence induction)

Recruiting
  • Respiratory Failure
  • Rapid sequence induction
  • Bern, Switzerland
    University Hospital Bern
Dec 3, 2021

Acute Respiratory Failure, Intubation Complication, Hypotension on Induction Trial in United States (Fluid Bolus, No Fluid

Completed
  • Acute Respiratory Failure
  • +2 more
  • Fluid Bolus
  • No Fluid Bolus
  • Birmingham, Alabama
  • +10 more
Aug 10, 2021

Renal Failure Trial in Columbus (Everolimus, Sirolimus)

Completed
Has Results
  • Renal Failure
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 2, 2021

Acute Renal Failure Trial in Burlington (Thymoglobulin, Thymoglobulin 0.75mg/kg dose)

Completed
Has Results
  • Acute Renal Failure
  • Burlington, Massachusetts
    Lahey Clinic
Feb 23, 2021

Severe Hemophilia A Trial (FVIII Concentrates, FVIII/VWF concentrates)

Withdrawn
  • Severe Hemophilia A
  • FVIII Concentrates
  • FVIII/VWF concentrates
  • (no location specified)
Dec 15, 2020

AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

Active, not recruiting
  • AML
  • Flotetuzumab dose escalation
  • +2 more
  • Duarte, California
  • +42 more
Mar 7, 2022

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Rapid Sequence Induction (RSI), Preoxygenation Trial in Brno (face-mask preoxygenation, HFNOC preoxygenation, HFNOC + face-mask

Not yet recruiting
  • Rapid Sequence Induction (RSI)
  • Preoxygenation
  • face-mask preoxygenation
  • +2 more
  • Brno, South Moravian Region, Czechia
    Brno University Hospital
Apr 26, 2023

Pregnancy Related Trial in Montpellier, Nîmes (Vaginal Dinoprostone system (Propess®), Dilatation balloon)

Recruiting
  • Pregnancy Related
  • Vaginal Dinoprostone system (Propess®)
  • Dilatation balloon
  • Montpellier, France
  • +1 more
Jul 28, 2022

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

Not yet recruiting
  • T-cell Lymphoblastic Lymphoma
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
  • Shanghai, Shanghai, China
  • +1 more
Dec 27, 2022